Article Details

BioCardia to Present CardiAMP Phase 3 Heart Failure Trial Results at ACC 2025 | BCDA Stock News

Retrieved on: 2025-01-27 14:27:46

Tags for this article:

Click the tags to see associated articles and topics

BioCardia to Present CardiAMP Phase 3 Heart Failure Trial Results at ACC 2025 | BCDA Stock News. View article details on hiswai:

Summary

The article discusses BioCardia's CardiAMP HF Phase 3 trial results presented by Dr. Amish N. Raval, highlighting its potential autologous cell therapy for heart healing. Tags like 'Amish N. Raval' and 'BioCardia, Inc.' align with this focus.

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up